Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 24:15:1476522.
doi: 10.3389/fpsyt.2024.1476522. eCollection 2024.

Acute salivary cortisol response in children with ADHD during psychosocial intervention with and without therapy dogs

Sabrina E B Schuck  1 , Cassie N Zeiler  1 , Annamarie Stehli  1 , Lydia A Steinhoff  1 , Rachel Y Stokes  1 , Sara E Jeffrey  1 , Douglas Alan Granger  2   3
Affiliations

Acute salivary cortisol response in children with ADHD during psychosocial intervention with and without therapy dogs

Sabrina E B Schuck et al. Front Psychiatry. .

Abstract

Introduction: Children with Attention Deficit/Hyperactivity Disorder (ADHD) participated in a randomized clinical trial comparing animal-assisted intervention (AAI) to psychosocial treatment as usual (TAU). This brief report describes effects of AAI on acute HPA axis reactivity and regulation. Saliva was collected before, during, and after psychosocial intervention sessions with and without therapy dogs and later assayed for cortisol (ug/dL).

Methodology: Thirty-nine participants (n = 39) with ADHD, aged 7-9 years (79% male) provided saliva at 3 points during 90-minute sessions; (i) upon arrival, (ii) +20 minutes, and (iii) 15 minutes prior to departure, on 3 occasions across an 8-week intervention (weeks 1, 4, and 8). Cortisol slopes calculated within each session were compared across the intervention weeks to determine within subject and between group effect sizes. Spearman's correlations between baseline individual neurodevelopmental symptoms and in-session acute cortisol responses were also evaluated.

Results: No significant between group differences were observed in cortisol responsiveness at week-1. By week-4, in-session changes in cortisol were evident, with significantly greater decreases in the AAI group (Cohen's d = -.40). This pattern was also observed at week-8, with an even stronger effect-size (d = -0.60). Concurrent symptoms of autism were associated with the in-session acute cortisol response. Specifically, higher parent-reported symptom scores were associated with steeper decreases in cortisol across the session at week 1 (r = -0.42, p <.01) and week-8 (r = -0.34 p = .05). At week-8 this association was stronger in the AAI group (r = -0.53) versus TAU (r = -0.25), with Cohen's q = 0.413).

Discussion: AAI may influence acute HPA reactivity and regulation for children with ADHD. Concurrent symptoms of ADHD and autism may be related to individual differences in the nature of the effect. Implications of these findings for AAI as an alternative, or complementary intervention for ADHD are discussed.

Clinical trial registration: ClinicalTrials.gov, identifier NCT05102344.

Keywords: animal assisted interventions; attention deficit hyperactivity disorder (ADHD); autism symptomatology; cortisol (Cor); psychosocial skills intervention; school-based intervention; therapy dogs.

PubMed Disclaimer

Conflict of interest statement

DG is Chief Scientific and Strategy advisor at Salimetrics LLC and Salivabio LLC. These relationships are managed by the policies of the committees on conflict of interest at the JHU School of Medicine and UCI. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Mean levels of in-session cortisol by group across intervention.
Figure 2
Figure 2
Correlation between week 1 in-session slope and ASRS t-score.
Figure 3
Figure 3
Correlation between week 8 in-session slope and ASRS t-score.
See this image and copyright information in PMC

References

    1. Caye A, Swanson JM, Coghill D, Rohde LA. Treatment strategies for ADHD: an evidence-based guide to select optimal treatment. Mol Psychiatry. (2019) 24:390–408. doi: 10.1038/s41380-018-01163 - DOI - PubMed
    1. Danielson ML, Bitsko RH, Ghandour RM, Holbrook JR, Kogan MD, Blumberg SJ. Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. children and adolescents, 2016. J Clin Child Adolesc Psychol. (2018) 47:199–212. doi: 10.1080/15374416.2017.1417860 - DOI - PMC - PubMed
    1. Mechler K, Banaschewski T, Hohmann S, Häge A. Evidence-based pharmacological treatment options for ADHD in children and adolescents. Pharmacol Ther. (2022) 230:107940. doi: 10.1016/j.pharmthera.2021.107940 - DOI - PubMed
    1. Wojnowski N, Zhou E, Jee Y. Effect of stimulants on final adult height. J Pediatr Endocrinol Metab. (2022) 35:1337–44. doi: 10.1515/jpem-2022-0344 - DOI - PMC - PubMed
    1. Schuck SE, Emmerson NA, Fine AH, Lakes KD. Canine-assisted therapy for children with ADHD: preliminary findings from the positive assertive cooperative kids study. J Atten Disord. (2015) 19:125–37. doi: 10.1177/1087054713502080 - DOI - PMC - PubMed

Associated data